Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

TSX:OPS - Post Discussion

Opsens Inc > Globe & Mail
View:
Post by retiredcf on Apr 05, 2023 9:53am

Globe & Mail

08:04 AM EDT, 04/05/2023 (MT Newswires) -- Opsens Inc. (OPS.TO), a cardiology-focused medical device company, said Wednesday that its SavvyWire solution has been successfully used by physicians in 1,000 procedures.

Opsens said SavvyWire is a sensor-guided solution for transcatheter aortic valve replacement procedures to treat aortic valve stenosis.

"The successful use of the SavvyWire in 1,000 patients marks an important milestone towards full-scale commercialization of our innovative device," President and CEO Louis Laflamme said.

"The early commercialization phase is progressing steadily and the impressive number of procedures completed demonstrates the acceptance and relevance of the SavvyWire within the structural heart market."

Comment by GoldenArm on Apr 05, 2023 3:56pm
News is good. How many proceedure in a year to turn a profit is the big thing. Are they a cash sucking machine or can they get to profitability before crashing from the weight of it all. Been in this so long I'm getting a bit anxious for results in terms of economics.
Comment by retiredcf on Apr 05, 2023 4:16pm
Today was a very good example of why you don't trust SP moves, particularly early in the day. Lots of sandbagging done to make the SP appear weak and/or a lack of interest from investors. It's the last half hour of the day that will tell you exactly how the market reacts to the news. And obviously, they like it. GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities